The insider ownership percentage is the key
indicator, can be used by investors, to measure the outlook of senior
management has on their company. Insider ownership for the EW is 0.20%. Institutional
ownership refers to the ownership stake in a company that is held by large
financial organizations, pension funds or endowments. The Institutional
ownership for the EW is 86.50%.
Insider trading is the buying or selling of any publicly traded company’s stock
and this can be done by someone who has non-public, material information about
that EW. Insider trading can be illegal or legal depending on when the insider
makes the trade. It is illegal when the material information is still non-public.
The insider transactions of the company (6-month change in insider ownerships)
for the Edwards Lifesciences Corporation (NYSE:EW) is -42.48%.
Institutional ownership is the amount of a Edwards Lifesciences Corporation
(NYSE:EW)’s available stock owned by mutual or pension funds, insurance
companies, investment firms, private foundations, endowments or other large
entities that actually manage the funds on the behalf of others, so its an
interesting element for the traders to note it, and the Institutional ownership
for the EW is -1.03%.
U.S traded Edwards Lifesciences Corporation (NYSE:EW) stock advanced 0.29% on
Monday and when day-trade ended the stock finally concluded at $185.27 and
number of shares that changed hands during the day are 1.84 Million. The number
of shares EW stock currently held by all its shareholders are 209.28 and
floated shares, the number of shares are available for trading in an open
market on last trading day are 207.17. The average volume of shares for 3
months is 1310.29 and EW stock value has moved between $134.25 – 197.1 in last
one year.
The Edwards Lifesciences Corporation (NYSE:EW)’s latest earnings date is
7/23/2019. The Gross margin is the difference between the revenue and the cost
of goods sold (COGS), divided by revenue. In other words, Gross Margin is a
percentage value, while Gross Profit is a monetary value. The valuable gross
margin for Edwards Lifesciences Corporation (NYSE:EW) is 75.50% and the profit
margin is 20.00% and the stock has gained 20.96% in 2019 to date.
U.S. traded shares of Edwards Lifesciences Corporation (NYSE:EW)’s monthly
stock performance is 8.54%, the quarterly performance is -2.49%, the half year
performance is calculated as 23.18%. The yearly performance of EW is 26.27%.
The higher the volatility, the riskier the security. For example, when the
stock market rises and falls more than one percent over a sustained period of
time, it is called a “volatile” market, if the stock price stays
relatively stable, the security has low volatility. The Edwards Lifesciences
Corporation (NYSE:EW) weekly volatility is measured as 1.83% and monthly
volatility measured as 1.91%.
Return on assets (ROA) is a main indicator of how profitable a company is
relative to its total assets. EW return on assets is 13.60%, the return on
equity (ROE) of the Edwards Lifesciences Corporation (NYSE:EW) is 23.30%, while
the most important return on investment is calculates as a percentage and is
typically used for personal financial decisions, and EW return on investment is
19.60%.
The price to earnings ratio is 49.44, price to sales ratio is 10.15, and price
to book ratio is 11.17, price to cash per share ration is 40.26, price to free
cash flow is 71.90.
Analysts mean target price for Edwards Lifesciences Corporation (NYSE:EW) is
$193.11 while analysts mean recommendation is 2.30. The current share price
indicates that stock is -6.36% away from its one year high and is moving 37.72%
ahead of its 52-week low. EW’s distance from 20 day simple moving average is
0.14% and distance from 50-Day simple moving average is 3.23%.
